ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

In Brief: Congresswomen Receive FASEB Awards for Public Service for Support of NIH

May 2, 1997

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990